Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q1 FY24 Earnings Presentation
13 slides from Amrutanjan Health Care's earnings presentation, Aug 4, 2023
Slide 1: Exchange filing cover letter for investor presentation
AHCL/ SE/ 30 /2023-24 August 4, 2023 The National Stock Exchange of lndialimited BSE Limited "Exchange Plaza", C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Sandra (E) ist Floor, Mumbai 400 051 P.J. Towers, Dalal Street, Mumbai 400 001 Symbol: AMRUTANJAN Scrip Code: 590006 Dear
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation - Quarter Ended 30th June 2023 Date: 2nd August 2023
Slide 3: Contents
Contents a. Business Update b. Q1 FY24 Performance c. Way Forward Investor Presentation | Quarter Ended 30th June 2023 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter Ended 30th June 2023 3
Slide 5: Business Update
Business Update • Headache Pain management category has bottomed in q4 and has shown small growth in q1(source:IQVIA) We predict annual growth to return to around 9% for the year (value). • Comfy business shows strong demand driven growth. • E plus brand continues to be a growth driver for beverage
Slide 6: Q1 FY24 Performance
Q1 FY24 Performance Investor Presentation | Quarter Ended 30th June 2023 5
Slide 7: Financials – Q1 FY24
Financials – Q1 FY24 (Rs. in Crores) Net Sales Profit Before Tax Profit After Tax 9.43 7.01 77.86 70.95 5.25 3.66 Q1 FY24 Q1 FY23 Q1 FY24 Q1 FY23 Q1 FY24 Q1 FY23 Growth: 9.74% Growth: 79.62% Growth: 91.53% Investor Presentation | Quarter Ended 30th June 2023 6
Slide 8: Financials – Q1 FY24
Financials – Q1 FY24 (Rs. in Crores) Employee Benefit Expenses 11.37 12.11 Q1 FY24 Q1 FY23 Decrease: 6.11% Advertisement & Selling Expenses Other Expenses 9.89 12.18 10.63 6.54 Q1 FY24 Q1 FY23 Q1 FY24 Q1 FY23 Decrease: 33.87% Increase: 14.58% Investor Presentation | Quarter Ended 30th June 2023 7
Slide 9: Financials – Q1 FY24 – OTC Division
Financials – Q1 FY24 – OTC Division (Rs. in Crores) Net Sales - OTC 66.15 62.41 Notes: • Majority of raw material prices are lower than Q1 FY23. Menthol price is marginally higher than Q1 FY23. Q1 FY24 Q1 FY23 Growth: 5.99% • Majority of packing material prices are lower than Q1 FY23. Net Sales - Co
Slide 10: Financials – Q1 FY24 – Beverage Division
Financials – Q1 FY24 – Beverage Division (Rs. in Crores) Net Sales - Beverages 11.29 7.96 Notes: • Raw Material & Packing Material Q1 FY24 Q1 FY23 prices are higher when compared to Q1 FY23. Growth: 41.83% • Advertisement spend is at Rs. 1.90 Net Sales - Electro Plus cr for Q1 FY24 against Rs. 1.35
Slide 11: Way Forward
Way Forward Investor Presentation | Quarter Ended 30th June 2023 10
Slide 12: Way Forward
Way Forward We remain focused on executing our key priorities: • Expand distribution • Go global • Grow E-Commerce vertical • Costs reduction Investor Presentation | Quarter Ended 30th June 2023 11
Slide 13: Investor Presentation | Quarter Ended 30th June 2023
Investor Presentation | Quarter Ended 30th June 2023 12
Amrutanjan Health Care — Q1 FY24 Earnings Presentation on 6ix